Insulin makers, PBMs face competition claims from Pa. over prices

( October 13, 2026, 15:55 GMT | Official Statement) -- MLex Summary: Pennsylvania Attorney General Dave Sunday announced a lawsuit against several pharmaceutical companies and pharmacy benefit managers regarding an alleged conspiracy to manipulate insulin price markets, increasing out-of-pocket costs for patients. According to the complaint, Eli Lilly and Co., Novo Nordisk and Sanofi-Aventis US, and numerous PBMs including Express Scripts, CVS Caremark and Optum RX, conspired to inflate prices by more than 1,000 percent. Statement follows in full. Also see attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents